Research Reports

Concord Biotech Shares

Concord Biotech company logo

Concord Biotech

PHYSICAL

Price Chart

1W
1M
1Y
MAX

High

-

Low

-

Return

-

No data available

Buy Sell Concord Biotech

As of May 21, 2026, Concord Biotech Limited, Listed Shares are trading at ₹0.00 per share.

Profit After Tax

info icon

174.95 Cr

Total Revenue

info icon

712.93 Cr

Category

info icon

Listed

Cashflow - Operations

info icon

207.47 Cr

About Concord Biotech

  • Concord Biotech (or, "The Company") is an India-based biopharma company. It is one of the global developers and manufacturers of select fermentation-based APIs across immunosuppressants, anti-infectives, and oncology therapies.
  • The company is a vertically integrated, R&D-driven bio-pharma company, that specializes in manufacturing Active Pharmaceutical Ingredients using fermentation & semi-synthetic processes, as well as finished formulations.
  • The company has a portfolio of 22 fermentation-based APIs and 65 approved products for formulations.
  • The company also offers Contract Research and Manufacturing Services (CRAMS), whereby it collaborates with third-party pharmaceutical companies to develop APIs and formulations.
  • Established in 2000, the Company has evolved from a single-product entity to a versatile solution provider, catering to various therapeutic segments.
  • The company's current business model comprises an integrated platform that involves conducting R&D activities, patent filing, manufacturing Key Starting Materials (KSMs) and APIs, producing formulations, and handling the marketing and distribution of these products.
  • During FY22, the company commissioned its new fermentation-based API facility at Limbasi, which is one of the largest fermentation facilities in the world.
  • The Company's API manufacturing facilities are situated in Dholka and Limbasi, while its formulations facility is located in Valthera, Gujarat, India.
  • The company's journey began as 'Servomed Pharmaceuticals Private Limited' in Ahmedabad, Gujarat on November 23, 1984. Subsequently, it was renamed to 'Concord Pharmaceuticals Private Limited.' The registered office is located in Dholka, Ahmedabad (Gujarat).

Want to See a Detailed Investment Analysis?

Explore in-depth financial analysis, performance metrics, and key disclosures.

Concord Biotech Media

News

Articles

Videos

Concord Biotech IPO opening on August 4

Concord Biotech IPO opening on August 4

30 Jul 2023

Jhunjhunwala-backed Concord Biotech sets IPO price band at Rs 705-741

Jhunjhunwala-backed Concord Biotech sets IPO price band at Rs 705-741

30 Jul 2023

Concord Biotech receives SEBI approval to launch IPO

Concord Biotech receives SEBI approval to launch IPO

05 Dec 2022

Frequently Asked Question (FAQs)

Where can I find the annual report of Concord Biotech Limited Ltd?

The annual report of Concord Biotech Limited Ltd is available in the annual report section.

How to buy Concord Biotech Limited Listed Shares?

Please find below the procedure for buying Concord Biotech Limited Listed Shares at Planify.
• 1. You confirm booking of Concord Biotech Limited Listed Shares with us at a trading price.
• 2. You provide your client master report (ask the broker if not available) along with PAN Card and Cancelled Cheque in case you are not transferring funds from the bank account as mentioned in the CMR Copy. These are KYC documents required as per SEBI regulations.
• 3. We will provide the bank details.
• 4. You need to transfer funds in that account.
• 5. Payment has to be done in RTGS/NEFT/IMPS CHEQUE TRANSFER. No CASH DEPOSIT.
• 6. Payment has to be done from the same account in which shares are to be credited.
• 7. We will transfer the shares in 24 hours if funds are credited before 2 pm.
Important Note: Please note that the lock-in period for selling Concord Biotech Limited Listed Shares is 6 months after listing. Hence you can’t sell Concord Biotech Limited Listed Shares which you bought in Pre-IPO for 6 months after its listing. i.e. You can sell it only after 6 months calculated from the listing date.

What is the lock-in period of Concord Biotech Limited Listed Shares?

Lock-in period of Concord Biotech Limited Listed Shares depends upon category of investors.
• 1. Venture Capital Funds or Alternate Investment Fund of Category -I or II, or Foreign Venture Capital Investor - lock-in Period of 6 months from the date of acquisition of Concord Biotech Limited Listed Shares.
• 2. Other Investors (include Retail, HNIs or Body Corporate) lock-in Period of 6 months from the date of listing of IPO of Concord Biotech Limited Listed Shares.
This new SEBI rule was introduced in the month of August-2021, wherein the SEBI has reduced the lock-in period previously from 1 year to 6 months to encourage more and more funds to be invested in startups which are going to public or IPO in near future. Reduction of lock-in is seen as big step and after that many PMS funds are advising their clients to invest in Pre-IPO shares to get the benefit of early stage investment.

See More

Concord Biotech

₹ -

cartIcon